Creative Biolabs-Immuno-oncology

Anti-DOC2B (clone N1G5L0Z-2E1G) SynExpress T7-Cy3-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR2222)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DOC2B (clone N1G5L0Z-2E1G). We employs the Lentivirus (T7-Cy3-IL-10-EcoRI) vector components and the SynExpress system of the Single base pair Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DOC2B
Clone
N1G5L0Z-2E1G
Species Reactivity
Mammalian
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
T7
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.96
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.